210 likes | 316 Views
Laboratory Regulations & Compliance Roundtable:. Latest Updates and Federal & State Actions By: Mark S. Birenbaum , Ph.D. Administrator American Association of Bioanalysts (AAB) National Independent Laboratory Association (NILA) May 2011 . . American Association of Bioanalysts (AAB).
E N D
Laboratory Regulations & Compliance Roundtable: Latest Updates and Federal & State Actions By: Mark S. Birenbaum, Ph.D. Administrator American Association of Bioanalysts (AAB) National Independent Laboratory Association (NILA) May 2011 .
American Association of Bioanalysts (AAB) Founded in 1956 Members Directors, Owners, Managers, Supervisors Laboratories (NILA) Associate Members (MTs, MLTs)
American Association of Bioanalysts (AAB) AAB Proficiency Testing Service (PTS) Operating since 1949 Founded American Board of Bioanalysis (ABB) in 1968
National Independent Laboratory Association (NILA) AAB Special Interest Group Members are Laboratories Focus on Ownership and Senior Management Founded in 2006
Clinical Laboratory Coalition (CLC) Loosely Structured Coalition that Addresses Reimbursement Issues Launched in 1995 at the Suggestion of Robert Waters/Mark Birenbaum
Clinical Laboratory Coalition (CLC) Laboratory Associations 1. American Association of Bioanalysts (AAB) 2. American Association for Clinical Chemistry (AACC) 3. American Clinical Laboratory Association (ACLA) 4. American Medical Technologists (AMT 5. American Society for Microbiology (ASM) 6. American Society for Clinical Pathology (ASCP) 7. American Society for Clinical Laboratory Science (ASCLS) 8. Clinical Laboratory Management Association (CLMA) 9. College of American Pathologists (CAP) 10. National Independent Laboratory Association (NILA) Members
Clinical Laboratory Coalition (CLC) Other Health Care Associations 1. Advanced Medical Technology Association (AdvaMed) 2. American Health Care Association (AHCA) 3. American Hospital Association (AHA) 4. American Medical Association (AMA) [on occasion] Individual Laboratories/Clinics 1. Sonic - USA 2. Quest 3. LabCorp 4. Others (varies) Members
Clinical Laboratory Coalition (CLC) Major Accomplishments Include: 2003 - Successfully Opposed Reimposition of 20% Part B Copayment. 2006 - Successfully Opposed CMS’s Competitive Bidding Demonstration Project. 2010-2011 - Successfully Opposed CMS Requirement for Physician Signatures on Part B Requisitions.
Physician Signature Requirement for Part B Requisitions http://www.youtube.com/watch?v=DZIPCFoscuA Unanimity Among CLC Members CLC Added Participants (AMA, AHCA, etc.) Use of YouTube Video Prepared by Annette Iacono (Brookside Laboratory)
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) History New York’s Clinical Laboratory Evaluation Program (CLEP) paid for by inspection and reference fees assessed on permitted laboratories. The fees collected are supposed to equal the cost of the CLEP program. Each laboratory pays a percent of CLEP’s expenses equal to that laboratory’s percent of New York Laboratory revenues.
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) History, continued From 1980s to mid-1990s, CLEP’s cost rose from about $3 million to $6 million per year (Inflation grew about 55-60% during that time). Over a 2 to 3 year period in the mid-1990s, CLEP expenses nearly tripled, from $6 million to over $15 million. In 1998, AAB formally inquired as to the reason for the large increase.
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) History, continued AAB discovered that many expenses being charged by CLEP were clearly inappropriate. After NYSDOH refused to return overpayments, AAB filed suit in 1999.
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) History, continued During discovery phase of litigation, AAB discovered: Many expenses charged by CLEP were unrelated to regulating clinical laboratories. NYSDOH failed to keep accurate records of some CLEP expenses.
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) History, continued After 7 years of litigation, trial court ruled in AAB’s favor and ordered NYSDOH to recalculate CLEP fees correctly and refund overpayments. NYSDOH appealed lower court rulings over next 5 years. In February 2011, NYSDOH exhausted its appeals.
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) Final Result After recalculating CLEP fees from 1998-2006, NYSDOH determined that 78% of the CLEP fees should be returned. CLEP fees returned totaled $5,041,377.45 to 35 laboratories represented by AAB. Refund checks were cut on March 28-30, 2011.
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) The Money Trail: Total CLEP fees collected from 1998 to 2006 were approximately $123 million. 78% of $123 million = $96 million Interest of 4% on $96 million (from 1998-2006) estimated at $17 million Total income for NYSDOH, including time value of money, = $96 million + 17 million = $113 million Fees Returned = $5 million Total Retained “unearned” income for NYSDOH = $108 million
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) The Money Trail:, continued NYSDOH did NOT have to pay interest on returned money. NYSDOH did NOT have to pay AAB’s legal expenses. NYSDOH did NOT reprimand, discipline, or terminate any officials responsible for overcharges. Several NYSDOH employees who criticized CLEP’s overcharges suffered negative consequences.
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) Lessons: Beginning in the mid-90s, CLEP intentionally overcharged New York laboratories. The New York legislature did not penalize CLEP for this unauthorized behavior. Instead, the New York legislature granted new powers to CLEP.
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) Lessons:, continued The only way to combat this behavior is for the entire laboratory community to oppose it. Number of plaintiffs in AAB Lawsuit covering 1998-2006: 35 Number of plaintiffs in AAB lawsuit covering 2007-2011: 105 Number of laboratories regulated by CLEP: 450-900
Lawsuit: AAB vs. New York State Department of Health (NYSDOH) Lessons:, continued As long as the majority of New York laboratories accept this behavior, it will continue and possibly worsen.